This site uses cookies, including third-party cookies, that help us to provide and improve our services. Privacy Policy

Peptide Based Cardiovascular Therapeutics Market

Peptide Based Cardiovascular Therapeutics Market

Peptide Based Cardiovascular Therapeutics Market Forecast, Trend Analysis & Competition Tracking: Global Market insights 2017 to 2022

Peptide Based Cardiovascular Therapeutics Market
FACT191MR
  • Aug-2017
  • List of Tables : 140
  • List of Figures : 42
  • 170 Pages
  • Healthcare

Introduction

Cardiovascular disease is the leading cause of mortality and morbidity all over the world. In the past, the development of peptides as therapeutic agents had been avoided by pharmaceutical industry due to their low stability, rate of degradation and poor delivery.

However, in recent times, resurgence has taken place in the field of peptides as therapeutics. Economic factors such as increasing healthcare expenditure and increasing FDI in emerging economies are expected to drive the market of peptide based cardiovascular therapeutics.

Additionally, increasing prevalence of cardiovascular disorders, emergence of prominent pharmaceutical and biotech companies and strong R&D in the development of new peptides are fuelling the market growth.

However, various factors such as increasing costs of commercialization, rapid metabolism of peptide drugs and regulatory conditions are expected to hamper market growth.

Therapeutic peptides are used in the treatment of cardiovascular disorders that are a leading cause of mortality and morbidity throughout the world. Peptides are short chains of amino acid monomers linked by peptide (amide) bonds.

Such type of covalent chemical bonds are formed when the carboxyl group of one amino acid reacts with the amino group of another. Peptides are differentiated from proteins on the basis of size, and peptides contain 50 amino acids or less approximately.

This Fact.MR report on the global peptide based cardiovascular therapeutics market forecasts that the global peptide based cardiovascular therapeutics market will touch a value of nearly US$ 1,960 Mn in the year 2022 and grow at a robust CAGR during the assessment period.

Avail customized purchase options for your needs

North America Market Set to Dominate the Global Peptide Based Cardiovascular Therapeutics Market in Terms of Revenue

The market in North America is set to dominate the global peptide based cardiovascular therapeutics market in terms of value and this trend is projected to sustain itself throughout the assessment period.

North America peptide based cardiovascular therapeutics market is the most attractive market, growing at a robust CAGR over the assessment period.

An Adaptive Approach to Modern-day Research Needs

Bivalirudin Segment Poised to Touch a Value of Nearly US$ 1,360 Mn in 2022

As per the forecast of Fact.MR, the bivalirudin segment is expected to reach a value of nearly US$ 1,360 Mn in the year 2022. This represents a robust CAGR during the forecast period of 2017-2022.

Bivalirudin segment is expected to account for more than two-third of the revenue share of the drug segment by the year 2017 and is expected to lose market share by the end of the year 2022.

Hospital Pharmacies Segment to exhibit a CAGR of 8.9% During the Assessment Period

As per the forecast of Fact.MR, the hospital pharmacies segment is slated to touch a figure of nearly US$ 960 Mn in the year 2022. This represents a CAGR of 8.9% during the assessment period from 2017 till the year 2022.

This segment is expected to lose market share by the end of the year 2022. The hospital pharmacies segment is expected to account for more than half of the revenue share of the distribution channel segment by the year 2017.

Interested to Procure The Data

Competition Tracking

The report also profiles companies that are expected to remain active in the expansion of global peptide based cardiovascular therapeutics market through 2022, which include

  • AstraZeneca, plc
  • Corden Pharma GmbH
  • Ipsen S.A
  • Merck & Co.Inc.,
  • Pfizer Inc
  • Apotex HoldingsInc.,
  • Dr. Reddy's Laboratories Limited
  • Fresenius Kabi USA LLC
  • Novetide Ltd
  • Amneal Pharmaceuticals LLC.

Market Taxonomy

Drug
  • Bivalirudin
  • Eptifibatide
Distribution Channel
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
Region
  • North America
  • Latin America
  • Europe
  • Japan
  • APEJ
  • MEA

(Additional information, including cross-sectional data and country-wise analysis & forecast is available in the report)

Need an Exclusive Report for your Unique Requirement?

- Related Reports -

Bipolar Disorder Therapeutics Market

Bipolar Disorder Therapeutics Market will account for US$ 5.9 Bn in 2022 and reach a value of US$ 6....

Genetic Disorder Therapeutics Market

Genetic Disorder Therapeutics Market research report covers detailed information on Global Genetic D...

Oligonucleotide Synthesis Market

Oligonucleotide Synthesis Market is expected to rise at 11.5% value CAGR, likely to reach US$ 17 Bil...

Glaucoma Therapeutics Market

Glaucoma Therapeutics Market expects 4.2% CAGR by 2031. Growing number of eye diseases strengthen de...

- Our Clients -

Report Client

- Evaluate How Fact.MR's Report Can Help. -

Is the market research conducted by Fact.MR?

Yes, the report has been compiled by expert analysts of Fact.MR, through a combination of primary and secondary research. To know more about how the research was conducted, you can speak to a research analyst.

What research methodology is followed by Fact.MR?

Fact.MR follows a methodology that encompasses the demand-side assessment of the market, and triangulates the same through a supply-side analysis. This methodology is based on the use of standard market structure, methods, and definitions.

What are the sources of secondary research?

Fact.MR conducts extensive secondary research through proprietary databases, paid databases, and information available in the public domain. We refer to industry associations, company press releases, annual reports, investor presentations, and research papers. More information about desk research is available upon request.

Who are the respondents for primary research?

Fact.MR speaks to stakeholders across the spectrum, including C-level executives, distributors, product manufacturers, and industry experts. For a full list of primary respondents, please reach out to us.

Is a sample of this report available for evaluation?

Yes, you can request a sample, and it will be sent to you through an email.